Mindray Medical International Limited (NYSE:MR)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and marketer of medical devices in China.

Recs

0
Player Avatar DrRonPaul4Prez (22.66) Submitted: 12/2/2010 6:44:13 PM : Outperform Start Price: $25.43 MR Score: +12.67

With PricewaterhouseCoopers as its audit firm, there's much less of a concern about the integrity of the financial reports as is the case with other China based companies. I see this stock doing well when China stocks swing in favor. And I am putting my money where my mouth is...I invested today...this takes the China spot in my portfolio.

Featured Broker Partners


Advertisement